Hesham A. Abou‐Zied

EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules

Hesham A. Abou‐Zied, Bahaa G. M. Youssif, Mamdouh F. A. Mohamed et al. · Bioorganic Chemistry · 2019 · 141 citations

Medicine, Medicinal Chemistry, Oncology +17

Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors

Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr et al. · International Journal of Molecular Sciences · 2023 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF^V600E with promising antiproliferative properties

Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa et al. · Archiv der Pharmazie · 2022 · 24 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways

Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham et al. · Molecules · 2023 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou‐Zied et al. · Journal of Molecular Structure · 2023 · 19 citations

Pharmacy, Medicinal Chemistry, Oncology +14